AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT AGeron Corp • March 16th, 2007 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, ___________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, ___________ (______) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at a per share exercise price equal to the lesser of (i) 120% of the average of the closing bid price of the Common Stock on the Principal Exchange (as defined in that certain Securities Purchase Agreement, dated December 13, 2006, by and among the Company and the Buyers listed on the execution page thereof (the "Purchase Agreement")) for the five (5) Trading Day (as defined in the Purchase Agreement) period immediately prior to the Exercise Period Start Date (as defined below) and (ii) $12.14 (the "Exercise Price"). The term "Warrant Shares," as used herein, refers to the shares of Common
